C07C 323/25
The carbon skeleton being acyclic and saturated
Official title: the carbon skeleton being acyclic and saturated
C07C323/25 (The carbon skeleton being acyclic and saturated) appears on 627 US grants and 448 published applications in this corpus.
Search patents in C07C- Granted patents
- 627
- Published applications
- 448
- Assignees
- 339
- Inventors
- 1,424
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 3 | 0 |
| 1978 | 5 | 0 |
| 1979 | 6 | 0 |
| 1980 | 13 | 0 |
| 1981 | 14 | 0 |
| 1982 | 7 | 0 |
| 1983 | 4 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 7 | 0 |
| 1987 | 7 | 0 |
| 1988 | 9 | 0 |
| 1989 | 21 | 0 |
| 1990 | 17 | 0 |
| 1991 | 17 | 0 |
| 1992 | 17 | 0 |
| 1993 | 12 | 0 |
| 1994 | 9 | 0 |
| 1995 | 10 | 0 |
| 1996 | 17 | 0 |
| 1997 | 29 | 0 |
| 1998 | 16 | 0 |
| 1999 | 14 | 0 |
| 2000 | 10 | 0 |
| 2001 | 5 | 0 |
| 2002 | 24 | 25 |
| 2003 | 20 | 30 |
| 2004 | 22 | 19 |
| 2005 | 13 | 20 |
| 2006 | 5 | 17 |
| 2007 | 18 | 14 |
| 2008 | 11 | 14 |
| 2009 | 6 | 18 |
| 2010 | 9 | 9 |
| 2011 | 11 | 13 |
| 2012 | 10 | 17 |
| 2013 | 13 | 20 |
| 2014 | 17 | 17 |
| 2015 | 15 | 31 |
| 2016 | 22 | 15 |
| 2017 | 21 | 19 |
| 2018 | 12 | 29 |
| 2019 | 14 | 20 |
| 2020 | 18 | 15 |
| 2021 | 13 | 15 |
| 2022 | 11 | 16 |
| 2023 | 14 | 13 |
| 2024 | 11 | 16 |
| 2025 | 9 | 16 |
| 2026 | 7 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical29 Sep 2026US 12,746,202 B2National University Corporation Chiba University
- Process for the preparation of cysteamine bitartrate and product so obtained29 Sep 2026US 12,747,204 B2Recordati Industria Chimica e Farmaceutica S.p.A.
- Sulfur-containing lipids29 Sep 2026US 12,747,205 B2The University of British Columbia
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Synthetic methods using native chemical ligation in flow14 Apr 2026US 12,600,746 B2The University of Sydney
- Novel lipids and compositions for the delivery of therapeutics13 Aug 2026US 2026/0232810 A1Arbutus Biopharma Corporation
- Compounds and compositions for intracellular delivery of nucleic acid-based therapeutics and methods thereof30 Jul 2026US 2026/0216070 A1NanoTech Pharma Inc.
- Platinum complexes, related compositions, and uses thereof in cyanide counter-measures30 Jul 2026US 2026/0216120 A1Beth Israel Deaconess Medical Center, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Methods and materials for modulating nrf2 pathway7 May 2026US 2026/0124310 A1President and Fellows of Harvard College
Most cited
By later US patents
- Diagnostic media413US 4,647,447 ASchering Corporation · 1987
- Method of enhancing NMR imaging using chelated paramagnetic ions bound to biomolecules213US 5,021,236 ASchering Corporation · 1991
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Lipid containing formulations152US 8,642,076 B2Tekmira Pharmaceuticals Corporation · 2014
- Thiol-modified hyaluronan121US 6,884,788 B2Anika Therapeutics, Inc. · 2005